Wilmington Healthcare wins first client for new NHS transformation tracker
July 24, 2018 |
Product helps pharma identify opportunities and tailor solutions to a changing NHS
Healthcare intelligence provider Wilmington Healthcare has won its first client for an innovative new service that helps pharma keep abreast of change within local NHS organisations and better understand their strategic priorities. The Healthcare Transformation Tracker, which is a Key Account Management (KAM) tool, enables pharma to search lengthy NHS documents at the touch of a button to identify opportunities within specific regions and allocate resources appropriately.
The product, which is now being used by a top pharma company, helps industry follow NHS change within three critical categories – disease and therapy areas; infrastructure, such as NHS estates, finance and transport, and the NHS transformation agenda.
Searches can be conducted across NHS organisations, such as trusts and Clinical Commissioning Groups (CCGs), within a Sustainability and Transformation Partnership footprint. Documents that can be perused include STP plans, operating plans, commissioning plans and board meeting papers.
For example, by searching on the term ‘diabetes’, a client can find out what individual STPs and their constituent organisations are saying about it; how services are being redesigned for it in different geographical regions and what is happening to enable this change with regards to NHS infrastructure.
To ensure they are targeting the appropriate personnel within local NHS organisations, pharma can also use the tracker to keep abreast of structural changes. For example, it can find out if a specific group of CCGs has formally merged or is acting as a single entity.
The service replaces Wilmington Healthcare’s STP tracker, that was launched in 2016, and reflects the radical change that continues in the NHS as ten areas prepare to become Integrated Care Systems (ICSs).
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Accessing key influencers within the NHS is becoming increasingly difficult for pharma. When companies do secure meetings, they should have a sound grasp of what is happening within a specific locality and go armed with a tailored solution that meets clearly identified needs.
“The transformation tracker helps pharma operate in this strategic and highly targeted way by enabling it to quickly extract relevant snippets of information from lengthy strategic documents and follow changes within the NHS as they unfold in different ways across different parts of the country.”
Ends
Notes to Editors
For more information, please contact:
Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare launches new platform to map the formulary landscape
Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare appoints new Head of Digital
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...
How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it